Read this topic

Think of Hirano bodies as the hippocampus'sA brain structure central to forming new memories.Read more → cytoskeleton 'jamming up' — actin filaments that normally support the neuron's shape and transport machinery clump into rigid rod-shaped crystals instead of doing their job, and this happens more as neurons age or are stressed by Alzheimer's pathology.

• Hirano bodies are intracytoplasmic, eosinophilic, rod-shaped inclusions found predominantly in hippocampal CA1 pyramidal neurons and the subiculum.
• Ultrastructurally they are paracrystalline arrays built from actin and actin-associated proteins (including tropomyosin and vinculin-related proteins), reflecting a cytoskeletal accumulation rather than a protein-misfolding aggregate like tau or alpha-synuclein.
• They lie parallel to the long axis of the neuron, often at the interface between the cell body and a dendrite.
• Their density increases with normal ageing and rises further in Alzheimer's disease, but they are not specific to any single diagnosis.
• They are best regarded as a marker of chronic neuronal stress/degeneration in the hippocampal formation rather than a primary driver of cognitive decline.
• Hirano bodies also feature outside Alzheimer's disease: balloon cells (swollen, achromatic neurons) found alongside Hirano bodies are a characteristic combined pathological finding in Pick's disease (frontotemporal dementia), a distinct disease context from their more commonly tested hippocampal/Alzheimer's association.

• Eosinophilic, rod-shaped inclusions running parallel to the long axis of hippocampal pyramidal neurons.
• Concentrated in the CA1 sector on post-mortem examination.
• Electron microscopy showing paracrystalline arrays of actin and actin-associated proteins.
• Found alongside plaques and tangles in an Alzheimer's brain, or as an incidental ageing change.
• Post-mortem report describing swollen, achromatic (balloon) neurons together with Hirano bodies — this specific pairing points to Pick's disease/frontotemporal dementia rather than Alzheimer's disease.

• Hirano bodies (actin paracrystals, rod-shaped, CA1 hippocampusA brain structure central to forming new memories.Read more →) vs neurofibrillary tangles (hyperphosphorylated tau, flame/globose shape, paired helical filaments) — different protein, different shape, but both increase in Alzheimer's disease.
• Hirano bodies vs Lewy bodies (alpha-synuclein, round, substantia nigraA deep brain structure rich in dopamine cells whose loss causes Parkinson's disease.Read more →/cortex) — different protein and different anatomical hotspot.
• Hirano bodies vs Pick bodies (tau, round-oval, dentate gyrus/frontotemporal cortex in Pick's disease) — Pick bodies are argyrophilic and stain differently on silver stains.
• Hirano bodies are non-specific (seen in normal ageing too), unlike tangles and plaques whose density is used to formally stage Alzheimer's disease.
• Balloon cells (swollen, achromatic neurons) combined with Hirano bodies: a characteristic pathological pairing in Pick's disease/frontotemporal dementia, unlike the tangle-and-plaque pairing that instead characterises Alzheimer's disease.

• Assuming any hippocampal inclusion in an elderly brain must be a neurofibrillary tangle — always check the described composition (actin vs tau) and shape (rod vs flame/globose).
• Treating Hirano bodies as diagnostic of Alzheimer's disease — they are increased in frequency but also occur in normal ageing and are not part of the formal Braak staging criteria.
• Confusing the anatomical hotspot — Hirano bodies concentrate in CA1/subiculum, not substantia nigraA deep brain structure rich in dopamine cells whose loss causes Parkinson's disease.Read more → or frontal cortex.
• Forgetting that Hirano bodies are cytoskeletal (actin-based), not amyloid or tau-based, which changes which stains highlight them (eosin/electron microscopy rather than tau immunohistochemistry).

• Localise the clue to the relevant anatomical level, cell type, pathway or molecular process.
• Map that structure or process to its normal function.
• Predict the deficit or clinical sign produced when it is disrupted.
• Reject options that belong to a neighbouring structure, pathway or level of explanation.